One of the most important principles of sound investment management is staying on top of what’s happening in the world and how those events affect finances. Conditions change quickly, and keeping up-to-date on developments and trends can be challenging. The team of experts producing IWB have been advising Canadian investors for over 25 years.
Edited and Published by Gordon Pape. Associate Editor: Richard Croft
With Gavin Graham, Ryan Irvine, Glenn Rogers, Shawn Allen, Adam Mayers, Paul Bamford & Michael Corcoran.
Recent Issues
iwb22207 (February 14, 2022)
RRSP shake-up… Volatility returns… Richard Croft updates Equal Weight Banks ETF, Dow Jones Internet Index ETF, Global X U.S. Infrastructure Development ETF, Meta Platforms… Gordon Pape updates CGI Group, TFI International… Your Questions: Premium Income
iwb22206 (February 7, 2022)
It’s been 25 years!… ARK Innovation rout offers opportunity… Adam Mayers updates Emerge ARK Global Disruption Innovative ETF, Microsoft, Nutrien… Ford bets big on EVs… Gordon Pape’s updates: Alphabet, Amazon… Your Questions: Activision Blizzard
iwb22205 (January 31, 2022)
More inflation-sensitive ETFs… Glenn Rogers updates Rivian Automotive, Verizon Communications, AeroVironment, Bank of America, Teck Resources… How to invest when there’s nowhere to hide… Gordon Pape updates Suncor, UnitedHealth… Your Questions: Newport Exploration
iwb22204 (January 24, 2022)
Seeking an inflation refuge… Have growth stocks peaked?… Gold and inflation… Gavin Graham updates First Quantum Mining, Canadian Natural Resources, GlaxoSmithKline, Winpak… Gordon Pape’s updates: Tourmaline Oil… Your Questions: What about BAMR?
Recent Updates
Cameco Corp. (TSX: CCO, NYSE: CCJ)
Cameco is one of the world’s largest uranium producers, with mines at McArthur River and Cigar Lake in Saskatchewan and refineries in Ontario. As governments and investors have become more favourably inclined towards non-carbon emitting sources of baseload power such as nuclear in recent years, Cameco’s fortunes and its share price have revived.
Sell half
CGI Group (TSX: GIB.A, NYSE: GIB)
CGI is the fifth largest independent information technology and business process services firm in the world. The company, founded in 1976, delivers an end-to-end portfolio of capabilities, from IT and business consulting to systems integration, outsourcing services, and intellectual property solutions. It employs about 93,000 professionals in offices and delivery centres across the Americas, Europe, and the Asia Pacific region.
Hold
Bank of Nova Scotia (TSX, NYSE: BNS)
Scotiabank is the most internationally diversified of the major Canadian banks, with over 30% of its assets coming from its overseas operations, primarily what the bank describes as the three Pacific Alliance countries of Mexico, Peru, and Chile. It sold its subscale operations in Colombia, Panama, and Costa Rica to bank Davivienda in the first quarter in exchange for a 20% stake in Davivienda, taking a $1.4 billion impairment charge on the sale. Scotiabank has strengths in mortgage and corporate lending and wealth management and is usually the lowest cost operator amongst the major banks.
Buy
RBC Group (TSX, NYSE: RY)
RBC is the largest bank in Canada, with 23% market share after the acquisition of HSBC’s Canadian operations in late 2024. It has strengths in retail banking, investment banking, and asset management plus the largest share of mortgages and corporate lending in Canada.
Buy
Pfizer Inc. (NYSE: PFE)
Pfizer is a leading international pharmaceutical company that can trace its history back more than 170 years. Its business units include Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines, and Internal Medicine. Pfizer was the first company (along with partner BioNTech) to have a Covid vaccine approved for general use. It has proven to be highly effective with minimal side effects. The company has also developed a drug to treat the virus.